tiprankstipranks
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
US Market
COYA
Coya Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see COYA full AI Analyst Report?

Coya Therapeutics, Inc. (COYA) Income Statement

118 Followers

Coya Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), Coya Therapeutics, Inc.'s total revenue was $3.96M, an increase of 202768.80% from the same quarter last year. In Q4, Coya Therapeutics, Inc.'s net income was $-5.71M. See Coya Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.95M$ 3.55M$ 6.00M$ 0.00$ 0.00
Gross Profit
$ 7.92M$ -8.31M$ 500.68K$ -4.41M$ 0.00
Operating Expenses
$ 28.18M$ 8.94M$ 8.40M$ 5.40M$ 4.87M
Depreciation and Amortization
$ 27.36K$ 27.36K$ 27.36K$ 27.36K$ 16.13K
EBITDA
$ -20.24M$ -17.20M$ -7.33M$ -9.26M$ -4.85M
Operating Income
$ -20.27M$ -17.25M$ -7.90M$ -9.81M$ -4.87M
Other Income/Expenses
$ -957.39K$ 1.65M$ 639.37K$ -2.43M$ -21.48K
Pretax Income
$ -21.22M$ -15.60M$ -7.26M$ -12.24M$ -4.89M
Net Income
$ -21.23M$ -14.88M$ -7.99M$ -12.24M$ -4.89M
Per Share Metrics
Basic EPS
$ -1.27$ -0.98$ -0.79$ -1.23$ -0.74
Diluted EPS
$ -1.27$ -0.98$ -0.79$ -1.23$ -0.74
Weighted Average Shares Outstanding
 16.73M 15.24M 10.16M 9.95M 6.60M
Weighted Average Shares Outstanding (Diluted)
 16.73M 15.24M 10.16M 9.95M 6.60M
Currency in USD

Coya Therapeutics, Inc. Earnings and Revenue History